S. Schroeder et al., Reduction of restenosis by vessel size adapted percutaneous transluminal coronary angioplasty using intravascular ultrasound, AM J CARD, 83(6), 1999, pp. 875-879
Citations number
23
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Restenosis following percutaneous transluminal coronary angioplasty (PTCA)
remains a serious problem in interventional cardiology. Recent trials using
stent implantation have proposed a reduction in restenosis, presumably due
to a higher initial luminal gain. This study was conducted to evaluate if
the short- and long-term results following conventional PTCA may be favorab
le, if balloon dilation; was performed according to measurements gained by
intravascular ultrasound (IVUS) (vessel size adapted PTCA). The use of intr
acoronary stents might be omitted if comparable long-term results could be
achieved by this modified technique of balloon angioplasty. This unicenter
and nonrandomized pilot trial was initiated in January 1995 with 252 patien
ts who had 271 lesions, IVUS was performed before and after intervention to
determine the external elastic membrane (EEM) diameter at the lesion site.
The balloon catheter was sized according to the EEM diameter measured by I
VUS (EEM 10%). The mean balloon diameter was 4.1 +/- 0.5 mm, the dilation t
ime 130 +/- 60 seconds with a balloon pressure of 7.0 +/- 2.0 atm. Clinical
acute and 1-year long-term follow-up were obtained for all patients and fo
llow-up angiography in 71% of patients. Acute events occurred postintervent
ionally in 5 patients (2%). The cumulative event rate during long-term foll
ow-up was 14%. The angiographic restenosis rate (diameter stenosis >50%) af
ter 1 year was 19%. Vessel size adapted PTCA using IVUS led to favorable ac
ute and long-term results with a low restenosis rate and a low 1-year clini
cal event rate. Despite dissections that occur frequently using large ballo
on sizes, on increased rate of major complications did not occur, indicatin
g a safe procedure and substantiating the philosophy of "therapeutic dissec
tions." The results need to be verified in a randomized trial. (C) 1999 by
Excerpta Medico, Inc.